Image (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 01)
Deferasirox Granule
Product Images NDC 69097-560
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69097-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 02)
90 mg (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 03)
This is a medication called Deferasirox Oral Granules, manufactured by Cipla. Each sachet contains 162 mg granule that is equivalent to 90 mg deferasirox. The medication guide is to be dispensed with it, and it is recommended to take the dosage as instructed by the doctor. The package is child-resistant, and it should be stored between 20°C to 25°C (68°F to 77°F). The lot number provided will be overprinted during commercial packing, and it contains 30 sachets. The patient should carefully open the sachet and pour the entire contents onto soft food like yogurt or apple sauce. The dose should be immediately consumed, and no granules should remain in the sachet.*
180 mg (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 04)
Deferasirox is an oral medication in the form of granules sold by Cipla. Each sachet contains 324 mg granule equivalent to 180 mg deferasirox, and the box contains 30 sachets. The patient must shake the sachet gently to settle the contents and tear it open along the cut line or use scissors to cut across it. The entire contents of the sachet must be poured on soft food such as yogurt or apple sauce. The dose must be consumed immediately, and not stored for future use. The medication must be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Each sachet must not be stored for more than a single use, and the package is child-resistant. The manufacturer of the medication is Cipla Ltd, Kurkumbh, India, and is manufactured for Cipla USA Inc.*
360 mg (Ce7e02d0 319e 4a5b 87e1 C6550ab4322c 05)
Deferasirox is an oral granule medication packaged in sachets manufactured by Cipla. Each sachet contains 648 mg granule equivalent to 360 mg deferasirox, and the medication guide must be dispensed with each pack. The patient should shake the sachet and tear it open along the cut line to carefully pour the entire contents on soft food before consumption. Deferasirox should be stored at 20°C to 25°C and protected from moisture. The package is child-resistant and comes in a batch with a serial number, lot number, and expiry date printed during commercial packing. The text includes instructions for the pharmacist and prescribing information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
